Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Discover concrete ways to improve a broken budget, from quick fixes to long-term habits that restore control over money.
15,518 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
When Nvidia's Jensen Huang just dropped a bold forecast at the company’s most watched event, investors sat up. This a...
York Space Systems stock jumped today as the company posted a revenue beat and improved growth indicators. This guide...
Across a century and a half, Western Union has defined cross-border payments. Yet fintech competition and shifting co...
Investing in rare earths sits at the intersection of policy, manufacturing demand, and new mining projects. This guid...
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
Nike remains a heavyweight in athletic wear, but its stock has faced pressure. This guide breaks down whether should ...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
Owlet's Q1 2026 earnings provide a window into revenue drivers, margins, and strategic pivots. This guide breaks down...
Berkshire Hathaway buying back stock isn’t just a headline. It reflects how the company views its own value and how i...